Avalo Therapeutics Files 8-K
Ticker: AVTX · Form: 8-K · Filed: May 8, 2025 · CIK: 1534120
| Field | Detail |
|---|---|
| Company | Avalo Therapeutics, INC. (AVTX) |
| Form Type | 8-K |
| Filed Date | May 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-K
Related Tickers: AVLO
TL;DR
AVLO filed an 8-K on 5/8/25. Standard reporting, check exhibits for details.
AI Summary
Avalo Therapeutics, Inc. filed an 8-K on May 8, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The company, formerly known as Cerecor Inc., is incorporated in Delaware and headquartered in Wayne, PA. This filing does not appear to contain specific financial transactions or material events beyond routine reporting.
Why It Matters
This 8-K filing indicates Avalo Therapeutics is meeting its regulatory reporting obligations. Investors should review the exhibits for any specific updates or disclosures.
Risk Assessment
Risk Level: low — The filing appears to be routine and does not disclose any new material events, significant financial changes, or strategic shifts.
Key Players & Entities
- Avalo Therapeutics, Inc. (company) — Registrant
- Cerecor Inc. (company) — Former company name
- May 8, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Wayne, PA (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing for Avalo Therapeutics?
This 8-K filing serves to report "Other Events" and "Financial Statements and Exhibits" as of May 8, 2025, fulfilling Avalo Therapeutics' regulatory reporting obligations.
What was Avalo Therapeutics' former name?
Avalo Therapeutics, Inc. was formerly known as Cerecor Inc.
In which state is Avalo Therapeutics incorporated?
Avalo Therapeutics, Inc. is incorporated in Delaware.
Where are Avalo Therapeutics' principal executive offices located?
Avalo Therapeutics, Inc.'s principal executive offices are located at 540 Gaither Road, Suite 400, Rockville, Maryland 20850.
What is the filing date for this 8-K report?
The filing date for this 8-K report is May 8, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 8, 2025 regarding Avalo Therapeutics, Inc. (AVTX).